Scott Jones
About Scott Jones
Scott Jones is a CMC Leader at Bristol Myers Squibb in New Brunswick, New Jersey, with over two decades of experience in various leadership roles within the company.
Company
Scott Jones is currently employed at Bristol Myers Squibb, a global biopharmaceutical company. He works out of their New Brunswick, New Jersey, United States location. His extensive tenure at Bristol Myers Squibb has seen him progress through multiple roles over two decades, showcasing his deep involvement in the development and commercialization of pharmaceuticals.
Title
Scott Jones holds the position of CMC Leader at Bristol Myers Squibb. CMC (Chemistry, Manufacturing, and Controls) leadership involves overseeing the strategies that bridge drug development and manufacturing to ensure that regulatory, quality, and commercial milestones are met.
Education and Expertise
Scott Jones achieved his Doctor of Philosophy (Ph.D.) in Chemical Engineering from the University of Delaware, studying from 1993 to 1998. His academic background laid a strong foundation for his subsequent roles in the pharmaceutical industry, where his expertise in chemical engineering has been pivotal to his leadership in drug product manufacturing and process development.
Career Background
Scott Jones began his career at Bristol Myers Squibb as a Principal Scientist, a role he held from 2001 to 2011. Over time, he transitioned through several key positions such as Associate Director - API Process Development, Site Director - Drug Product Manufacturing Science & Technology, and Head, Strategic Partner Management. These roles have spanned various locations, including New Jersey and Puerto Rico.
Leadership and Management
In his capacity as CMC Leader, Scott Jones is accountable for integrating development, manufacturing, control, and regulatory strategies with clinical and commercialization teams. He has a profound capability in managing cross-functional teams and developing comprehensive CMC strategies that align with clinical and commercialization timelines, ensuring cohesive execution across the pharmaceutical development lifecycle.